These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Pathological manifestation and feasibility of conservative breast surgery after effective neoadjuvant chemotherapy for breast cancer]. Liu CP, Shi L, Li Z. Zhonghua Wai Ke Za Zhi; 2008 Sep 15; 46(18):1394-6. PubMed ID: 19094510 [Abstract] [Full Text] [Related]
12. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma? Sullivan PS, Apple SK. Breast J; 2009 Sep 15; 15(2):146-54. PubMed ID: 19292800 [Abstract] [Full Text] [Related]
13. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S. Clin Cancer Res; 2009 Jun 15; 15(12):4234-41. PubMed ID: 19509181 [Abstract] [Full Text] [Related]
15. A nanoemulsion formulation of tamoxifen increases its efficacy in a breast cancer cell line. Tagne JB, Kakumanu S, Ortiz D, Shea T, Nicolosi RJ. Mol Pharm; 2008 Jun 15; 5(2):280-6. PubMed ID: 18171014 [Abstract] [Full Text] [Related]
19. Modification of composition of a nanoemulsion with different cholesteryl ester molecular species: effects on stability, peroxidation, and cell uptake. Almeida CP, Vital CG, Contente TC, Maria DA, Maranhão RC. Int J Nanomedicine; 2010 Sep 20; 5():679-86. PubMed ID: 20957219 [Abstract] [Full Text] [Related]
20. Axillary-conserving surgery is facilitated by neoadjuvant chemotherapy of breast cancer. Beatty JD, Precht LM, Lowe K, Atwood M. Am J Surg; 2009 May 20; 197(5):637-41; discussion 641-2. PubMed ID: 19321159 [Abstract] [Full Text] [Related] Page: [Next] [New Search]